With this additional regulatory approval, CephX becomes the only orthodontic AI diagnostic support company with FDA clearance for both 2D and 3D imaging.

Alongside this regulatory milestone, Orca Dental AI also announced expanded strategic integrations with DEXIS™ and Greyfinch, further embedding CephX’s AI-driven cephalometric analysis into leading imaging and practice management ecosystems worldwide.

Together, these developments strengthen CephX’s position as a connected AI diagnostic platform designed to support orthodontists and dental specialists with faster analysis, improved visualization, and more efficient clinical workflows.